Malin Pedersen

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Inflammatory Response

Herpes Simplex Virus

Top Venues

Journal for immunotherapy of cancer

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Edward Armstrong, Matthew K L Chiu, Shane Foo, Lizzie Appleton, Pablo Nenclares, Anton Patrikeev, Nitya Mohan, Martin Mclaughlin, Galabina Bozhanova, Julia Hoebart, Victoria Roulstone, Emmanuel C Patin, Malin Pedersen, Joan Kyula, Masahiro Ono, Fiona Errington-Mais, John Cameron Bell, Kevin J Harrington, Alan A Melcher, Victoria Jennings
Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signalling. Journal for immunotherapy of cancer 12 (7) (2024)
Edward Armstrong, Matthew K L Chiu, Shane Foo, Lizzie Appleton, Pablo Nenclares, Anton Patrikeev, Nitya Mohan, Martin Mclaughlin, Galabina Bozhanova, Julia Hoebart, Victoria Roulstone, Emmanuel C Patin, Malin Pedersen, Joan Kyula, Masahiro Ono, Fiona Errington-Mais, John Cameron Bell, Kevin J Harrington, Alan A Melcher, Victoria Jennings
Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signalling. Journal for immunotherapy of cancer 12 (7) (2024)
Edward Armstrong, Matthew K L Chiu, Shane Foo, Lizzie Appleton, Pablo Nenclares, Anton Patrikeev, Nitya Mohan, Martin Mclaughlin, Galabina Bozhanova, Julia Hoebart, Victoria Roulstone, Emmanuel C Patin, Malin Pedersen, Joan Kyula, Masahiro Ono, Fiona Errington-Mais, John Cameron Bell, Kevin J Harrington, Alan A Melcher, Victoria Jennings
Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signalling. Journal for immunotherapy of cancer 12 (7) (2024)
Edward Armstrong, Matthew K L Chiu, Shane Foo, Lizzie Appleton, Pablo Nenclares, Anton Patrikeev, Nitya Mohan, Martin Mclaughlin, Galabina Bozhanova, Julia Hoebart, Victoria Roulstone, Emmanuel C Patin, Malin Pedersen, Joan Kyula, Masahiro Ono, Fiona Errington-Mais, John Cameron Bell, Kevin J Harrington, Alan A Melcher, Victoria Jennings
Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signalling. Journal for immunotherapy of cancer 12 (7) (2024)
Edward Armstrong, Matthew K L Chiu, Shane Foo, Lizzie Appleton, Pablo Nenclares, Anton Patrikeev, Nitya Mohan, Martin Mclaughlin, Galabina Bozhanova, Julia Hoebart, Victoria Roulstone, Emmanuel C Patin, Malin Pedersen, Joan Kyula, Masahiro Ono, Fiona Errington-Mais, John Cameron Bell, Kevin J Harrington, Alan A Melcher, Victoria Jennings
Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signalling. Journal for immunotherapy of cancer 12 (7) (2024)
Ian Jones, Lucas G Dent, Tomoaki Higo, Theodoros Roumeliotis, Maria Arias Garcia, Hansa Shree, Jyoti Sharma Choudhary, Malin Pedersen, Chris Bakal
Characterization of proteome-size scaling by integrative omics reveals mechanisms of proliferation control in cancer. Science advances 9 (4) (2023)
Ian Jones, Lucas G Dent, Tomoaki Higo, Theodoros Roumeliotis, Maria Arias Garcia, Hansa Shree, Jyoti Sharma Choudhary, Malin Pedersen, Chris Bakal
Characterization of proteome-size scaling by integrative omics reveals mechanisms of proliferation control in cancer. Science advances 9 (4) (2023)
Ian Jones, Lucas G Dent, Tomoaki Higo, Theodoros Roumeliotis, Maria Arias Garcia, Hansa Shree, Jyoti Sharma Choudhary, Malin Pedersen, Chris Bakal
Characterization of proteome-size scaling by integrative omics reveals mechanisms of proliferation control in cancer. Science advances 9 (4) (2023)
Ian Jones, Lucas G Dent, Tomoaki Higo, Theodoros Roumeliotis, Maria Arias Garcia, Hansa Shree, Jyoti Sharma Choudhary, Malin Pedersen, Chris Bakal
Characterization of proteome-size scaling by integrative omics reveals mechanisms of proliferation control in cancer. Science advances 9 (4) (2023)
Galabina Bozhanova, Jehanne Hassan, Lizzie Appleton, Victoria Jennings, Shane Foo, Martin McLaughlin, Charleen Ml Chan Wah Hak, Emmanuel C Patin, Eva Crespo-Rodriguez, Gabby Baker, Edward Armstrong, Matthew Chiu, Hardev Pandha, Adel Samson, Victoria Roulstone, Joan Kyula, Richard Vile, Fiona Errington-Mais, Malin Pedersen, Kevin J Harrington, Masahiro Ono, Alan A Melcher
CD4 T cell dynamics shape the immune response to combination oncolytic herpes virus and BRAF inhibitor therapy for melanoma. Journal for immunotherapy of cancer 10 (3) (2022)
Emmanuel C Patin, Magnus T Dillon, Pablo Nenclares, Lorna Grove, Heba Soliman, Isla Leslie, Davina Northcote, Galabina Bozhanova, Eva Crespo-Rodriguez, Holly Baldock, Harriet Whittock, Gabriella Baker, Joan Kyula, Jeane Guevara, Alan A Melcher, James Harper, Hormas Ghadially, Simon Smith, Malin Pedersen, Martin McLaughlin, Kevin J Harrington
Harnessing radiotherapy-induced NK-cell activity by combining DNA damage-response inhibition and immune checkpoint blockade. Journal for immunotherapy of cancer 10 (3) (2022)
Eva Crespo-Rodriguez, Katharina Bergerhoff, Galabina Bozhanova, Shane Foo, Emmanuel C Patin, Harriet Whittock, Richard Buus, Syed Haider, Gareth Muirhead, Khin Thway, Kate Newbold, Robert S Coffin, Richard G Vile, Dae Kim, Martin McLaughlin, Alan A Melcher, Kevin J Harrington, Malin Pedersen
Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer. Journal for immunotherapy of cancer 8 (2) (2021)